In this study, a prominent reduction of CD4+ T cells was found in severe ASyS+COVID cases and a lower CD4/CD8 ratio could serve as a convenient biomarker to identify high-risk ASyS patients with COVID-19. This evidence concerns the gene CD4 and COVID-19.